Robert J. Fontana MDProfessor of Medicine, Division of Gastroenterology and Hepatology; Medical Director of Liver Transplantation, University of Michigan, Ann Arbor, Michigan
Dr. Fontana is a translational investigator with research interests in drug induced liver injury, acute liver failure, and viral hepatitis. Dr. Fontana is currently a Professor of Medicine and Medical Director of Liver Transplantation. He is a site investigator and co-chair of the Drug Induced Liver Injury Network (DILIN), an NIH consortium of sites investigating the pathogenesis and outcomes of DILI. Dr. Fontana is also the current Chair of the AASLD Hepatotoxicity Special Interest Group and has been a leading member of the US Acute Liver Failure Study Group since 1998.
Dr. Fontana receives research funding from the National Institutes of Health, Gilead Sciences, Bristol-MyersSquibb, Janssen pharmaceuticals, and Vertex.
Recent Contributions to PracticeUpdate:
- Liver Transplantation for Herbal and Dietary Supplements–Induced Acute Liver Injury in Asians
- Increase in Dietary Supplement–Related Liver Failure in the United States
- Idiosyncratic Drug-Induced Liver Injury Associated With Morbidity and Mortality Within 6 Months of Onset
- Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury